Immunotherapy Biomarkers: Overcoming the Barriers Symposium - Multifaceted Immunomonitoring to Identify Predictive Biomarkers for the Clinical Outcome of Immunotherapy-treated Melanoma PatientsApril 2016Bethesda, MDSummaryIn this slide presentation from "Immunotherapy Biomarkers: Overcoming the Barriers" Symposium in Bethesda, MD in April 2016, Dr. Christina Maccalli, PhD (Sidra Medical and Research Center, Doha Qatar) discusses multifaceted immunomonitoring techniques to identify biomarkers predictive of clinical outcome. Includes a discussion of how this approach was applied in a multicenter study.Disclaimer: Due to the rapidly-evolving field of cancer immunotherapy, some of the content on this page may be out of date. For current information from SITC on cancer immunotherapy, scroll down to view Related Entries and Links.#Industry #Oncologist #Pharmacist #Researcher#Biomarkers #Melanoma #PresentationSlides#Clinician #ImmuneCheckpointInhibitors
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us